<p>'...thoughtful dialogue from diverse viewpoints on how the pharmaceutical industry assesses its situation and how it is likely to evolve over the next couple of decades.' From the foreword by Andreas Fibig, Bayer Schering Pharma '...timely and relevant. ...As we try to survive and thrive in these interesting times, The Future of Pharma is just the sort of guidebook we need.' From the foreword by G. Steven Burrill, Burrill & Company 'Professor Smith has had remarkable access to senior leaders within the industry and as such, he is very well informed. ...Radical stuff indeed and that's why this book is well worth a read if only to stimulate thinking and debate.' Industrial Pharmacy '...this new book really has something new and different to say ...It's powerful, challenging stuff. According to the blurb, Smith has worked in the industry for thirty years ...and you can really tell. ...an essential read if you work in the pharmaceutical business or even if you're just interested in where it is heading. ' via Amazon.co.uk 'Brian Smith is very well-placed to analyse the problems of the pharma industry and predict its future. ...His background is important because it comes through every page of this highly readable, thought-provoking work. ...An excellent enjoyable read.' via Amazon.co.uk 'This unique book comes highly recommended to anyone with an interest in the future of the pharmaceutical industry. Irrespective of whether or not you are in agreement with the specifics of the predictions offered, it can't fail to engage your mind and encourage you to reconsider the industry and its future. ...I can only recommend that you read the book: Your time will be well invested.' via Amazon.co.uk '...I would recommended it to anyone working in Pharma at the moment.' via Amazon.co.uk</p>
Produktdetaljer
Om bidragsyterne
Professor Brian D. Smith began his career as a research chemist in a pharmaceutical R&D lab and then spent 20 years in technical and marketing roles before becoming an academic, author and adviser. Working at OUBS and SDA Bocconi, two of Europe's leading business schools, his research focuses on strategy creation and implementation in pharmaceutical and medical technology markets. Brian also runs a specialist consultancy that advises many of the world's largest companies in this sector. He is editor of the Journal of Medical Marketing, has written and co-written three major books and published many practitioner articles all of which can be seen at www.pragmedic.com